Cited by 633Cannabis and Cannabinoid ResearchMast cells and histamineInflammatory mediators and NSAID effects

The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

Open access

Facci, L, Dal Toso, R, Romanello, S, Buriani, A, Skaper, S D, Leon, A·1995·Proceedings of the National Academy of Sciences

DOI 10.1073/pnas.92.8.3376PMC PMC42169

Open this paper in CoChat — free account

Abstract

Mast cells are multifunctional bone marrow-derived cells found in mucosal and connective tissues and in the nervous system, where they play important roles in tissue inflammation and in neuroimmune interactions. Very little is known about endogenous molecules and mechanisms capable of modulating mast cell activation. Palmitoylethanolamide, found in peripheral tissues, has been proposed to behave as a local autacoid capable of downregulating mast cell activation and inflammation. A cognate N-acylamide, anandamide, the ethanolamide of arachidonic acid, occurs in brain and is a candidate endogenous agonist for the central cannabinoid receptor (CB1). As a second cannabinoid receptor (CB2) has been found in peripheral tissues, the possible presence of CB2 receptors on mast cells and their interaction with N-acylamides was investigated. Here we report that mast cells express both the gene and a functional CB2 receptor protein with negative regulatory effects on mast cell activation. Although both palmitoylethanolamide and anandamide bind to the CB2 receptor, only the former downmodulates mast cell activation in vitro. Further, the functional effect of palmitoylethanolamide, as well as that of the active cannabinoids, was efficiently antagonized by anandamide. The results suggest that (i) peripheral cannabinoid CB2 receptors control, upon agonist binding, mast cell activation and therefore inflammation; (ii) palmitoylethanolamide, unlike anandamide, behaves as an endogenous agonist for the CB2 receptor on mast cells; (iii) modulatory activities on mast cells exerted by the naturally occurring molecule strengthen a proposed autacoid local inflammation antagonism (ALIA) mechanism; and (iv) palmitoylethanolamide and its derivatives may provide antiinflammatory therapeutic strategies specifically targeted to mast cells ("ALIAmides").

Integrity signals

Registry

Crossref · 10.1073/pnas.92.8.3376

Cites

43 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1006/abio.1987.9999 · Cited by 65,515
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,388
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Manual of pharmacologic calculations with computer programs
(1988) · International Journal of Biochemistry · doi:10.1016/0020-711x(88)90084-5 · Cited by 1,458
Molecular cloning of a human cannabinoid receptor which is also expressed in testis
Gérard, C. M., Mollereau, C., Vassart, G., & Parmentier, M. (1991) · Biochemical Journal · doi:10.1042/bj2790129 · Cited by 698

Flagged first, then by citations

Show all 43 references

Sorted by citations

Items 201–300 of 633

Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
Giuffrida, A., & Piomelli, D. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00046-5 · Cited by 92
Accumulation of VariousN-Acylethanolamines IncludingN-Arachidonoylethanolamine (Anandamide) in Cadmium Chloride-Administered Rat Testis
Kondo, S., Sugiura, T., Kodaka, T., Kudo, N., Waku, K., & Tokumura, A. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0688 · Cited by 92
Cannabinoids for Treatment of MS Symptoms: State of the Evidence
Rice, J., & Cameron, M. H. (2018) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-018-0859-x · Cited by 91
Effects of palmitoylethanolamide on immunologically induced histamine, PGD2 and TNFα release from canine skin mast cells
Cerrato, S., Brazís, P., della Valle, M. F., Miolo, A., & Puigdemont, A. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.06.011 · Cited by 93
Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway
Powles, T. B., Poele, R. T., Shamash, J., Chaplin, T., PROPPER, D. J., Joel, S., Oliver, R. T. D., & Liu, W. M. (2004) · Blood · doi:10.1182/blood-2004-03-1182 · Cited by 90
Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
Petrosino, S., Cordaro, M., Verde, R., Moriello, A. S., Marcolongo, G., Schievano, C., Siracusa, R., Piscitelli, F., Peritore, A. F., Crupi, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00249 · Cited by 89
Cannabinoid CB2 Receptor-Mediated Anti-nociception in Models of Acute and Chronic Pain
Jhaveri, M. D., Sagar, D. R., Elmes, S. J. R., Kendall, D. A., & Chapman, V. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-8007-7 · Cited by 89
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB 2 receptors
Su, T., Zhao, Y. Q., Zhang, L., Peng, M., Wu, C. ‐., Pei, L., Tian, B., Zhang, J., Shi, J., Pan, H., et al. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00055.x · Cited by 89
Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems
PETROCELLIS, L. D., Bisogno, T., Ligresti, A., Bifulco, M., Melck, D. J., & Marzo, V. D. (2002) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2002.00094.x · Cited by 88
2,3‐Dihydro‐1‐Benzofuran Derivatives as a Series of Potent Selective Cannabinoid Receptor 2 Agonists: Design, Synthesis, and Binding Mode Prediction through Ligand‐Steered Modeling
Diaz, P., Phatak, S. S., Xu, J. J., Fronczek, F. R., Astruc‐Diaz, F., Thompson, C. M., Cavasotto, C. N., & Naguib, M. (2009) · ChemMedChem · doi:10.1002/cmdc.200900226 · Cited by 88
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
Roche, M., & Finn, D. P. (2010) · Pharmaceuticals · doi:10.3390/ph3082517 · Cited by 88
Neuropharmacology and therapeutic potential of cannabinoids
Pertwee, R. G. (2000) · Addiction Biology · doi:10.1080/13556210071252 · Cited by 85
A Saturated N‐Acylethanolamine Other than N‐Palmitoyl Ethanolamine with Anti‐inflammatory Properties: a Neglected Story…
Carbonare, M. D., Giudice, E. D., Stecca, A., Colavito, D., Fabris, M., D'Arrigo, A. M., Bernardini, D., Dam, M., & Leon, A. A. G. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01689.x · Cited by 87
Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms
Johanek, L. M., Heitmiller, D. R., Turner, M., Nader, N., Hodges, J., & Simone, D. A. (2001) · Pain · doi:10.1016/s0304-3959(01)00336-0 · Cited by 83
Formation of N-Acyl-phosphatidylethanolamines and N-Acylethanolamines
Hansen, H. S., Lauritzen, L., Moesgaard, B., Strand, A. M., & Hansen, H. H. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00396-1 · Cited by 85
MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models
Naguib, M., Diaz, P., Xu, J. J., Astruc‐Diaz, F., Craig, S., Vivas‐Mejia, P., & Brown, D. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.340 · Cited by 82
Click-Modified Anandamide siRNA Enables Delivery and Gene Silencing in Neuronal and Immune Cells
Willibald, J., Harder, J., Sparrer, K. M. J., Conzelmann, K., & Carell, T. (2012) · Journal of the American Chemical Society · doi:10.1021/ja303251f · Cited by 82
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis
Campora, L., Miragliotta, V., Ricci, E., Cristino, L., Marzo, V. D., Albanese, F., della Valle, M. F., & Abramo, F. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.7.988 · Cited by 81
Endocannabinoids and the Heart
Hiley, C. R. (2009) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318192671d · Cited by 81
Vasodilator actions of abnormal‐cannabidiol in rat isolated small mesenteric artery
Ho, W. ‐. V., & Hiley, C. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705160 · Cited by 80
Localization of cannabinoid receptors CB1, CB2, GPR55, and PPARα in the canine gastrointestinal tract
Galiazzo, G., Giancola, F., Stanzani, A., Fracassi, F., Bernardini, C., Forni, M., Pietra, M., & Chiocchetti, R. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1684-7 · Cited by 89
Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies
Tsuboi, K., Zhao, L.-Y., Okamoto, Y., Araki, N., Ueno, M., Sakamoto, H., & Ueda, N. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.03.005 · Cited by 79
Anandamide activates human platelets through a pathway independent of the arachidonate cascade
Maccarrone, M., Bari, M., Menichelli, A., Principe, D. D., & Finazzi‐Agrò, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00308-7 · Cited by 79
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation
Murphy, N., Cowley, T. R., Blau, C. W., Dempsey, C., Noonan, J., Gowran, A., Tanveer, R., Olango, W. M., Finn, D. P., Campbell, V. A., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-79 · Cited by 78
Analgesic, anti-inflammatory, and antipyretic activity
Vogel, H. G., & Vogel, W. H. (1997) · Springer eBooks · doi:10.1007/978-3-662-03333-3_8 · Cited by 78
N‐acylphosphatidylethanolamine‐hydrolysing phospholipase D lacks the ability to transphosphatidylate
Petersen, G. L., & Hansen, H. S. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00861-3 · Cited by 78
Brain Innate Immunity in the Regulation of Neuroinflammation: Therapeutic Strategies by Modulating CD200-CD200R Interaction Involve the Cannabinoid System
Hernangómez, M., Carrillo-Salinas, F. J., Mecha, M., Correa, F., Mestre, L., Loría, F., Feliú, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
Pharmacological treatment options for mast cell activation disease
Molderings, G. J., Haenisch, B., Brettner, S., Homann, J., Menzen, M., Dumoulin, F. L., Panse, J., Butterfield, J. H., & Afrin, L. B. (2016) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-016-1247-1 · Cited by 77
The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor‐independent pathway in hematopoietic cell lines
Derocq, J., Bouaboula, M., Marchand, J., Rinaldi, M. L., Ségui, M., & Casellas, P. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00275-0 · Cited by 77
Palmitoylethanolamide counteracts substance P-induced mast cell activation in vitro by stimulating diacylglycerol lipase activity
Petrosino, S., Moriello, A. S., Verde, R., Allarà, M., Imperatore, R., Ligresti, A., Mahmoud, A. M., Peritore, A. F., Iannotti, F. A., & Marzo, V. D. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1671-5 · Cited by 76
Effect of palmitoylethanolamide–polydatin combination on chronic pelvic pain associated with endometriosis: Preliminary observations
Indraccolo, U., & Barbieri, F. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.01.008 · Cited by 78
Palmitoylethanolamide Reduces Granuloma-Induced Hyperalgesia by Modulation of Mast Cell Activation in Rats
Filippis, D. D., Luongo, L., Cipriano, M., Palazzo, E., Cinelli, M. P., de Novellis, V., Maione, S., & Iuvone, T. (2011) · Molecular Pain · doi:10.1186/1744-8069-7-3 · Cited by 76
The actions of some cannabinoid receptor ligands in the rat isolated mesenteric artery
White, R., & Hiley, C. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702111 · Cited by 76
The pharmacological basis of contemporary pain management
MacPherson, R. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00090-5 · Cited by 76
Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents
Fowler, C. J. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(02)00218-7 · Cited by 76
Biology of Reproduction Highlights …
Schuel, H., & Burkman, L. J. (2005) · Biology of Reproduction · doi:10.1095/biolreprod.105.043273 · Cited by 75
A Novel Neuroimmune Mechanism in Cannabinoid-mediated Attenuation of Nerve Growth Factor–induced Hyperalgesia
Farquhar-Smith, W. P., & Rice, A. S. C. (2003) · Anesthesiology · doi:10.1097/00000542-200312000-00024 · Cited by 75
Human mast cells take up and hydrolyze anandamide under the control of 5‐lipoxygenase and do not express cannabinoid receptors
Maccarrone, M., Fiorucci, L., Erba, F., Bari, M., Finazzi‐Agrò, A., & Ascoli, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01223-0 · Cited by 75
Novel, Not Adenylyl Cyclase-Coupled Cannabinoid Binding Site in Cerebellum of Mice
Monory, K., Tzavara, E. T., Lexime, J., Ledent, C. A., Parmentier, M., Borsodi, A. D., & Hanoune, J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6635 · Cited by 75
The therapeutic potential of novel cannabinoid receptors
Kreitzer, F. R., & Stella, N. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.01.005 · Cited by 75
Putative neuroprotective actions of N-acyl-ethanolamines
Hansen, H. S., Moesgaard, B., Petersen, G. L., & Hansen, H. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00251-6 · Cited by 73
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
Patricelli, M. P., & Cravatt, B. F. (2001) · Vitamins and hormones · doi:10.1016/s0083-6729(01)62002-8 · Cited by 73
Pharmacology and potential therapeutic uses of cannabis
Hirst, R. A., Lambert, D. G., & Notcutt, W. G. (1998) · British Journal of Anaesthesia · doi:10.1093/bja/81.1.77 · Cited by 72
6-Methoxy-N-alkyl Isatin Acylhydrazone Derivatives as a Novel Series of Potent Selective Cannabinoid Receptor 2 Inverse Agonists: Design, Synthesis, and Binding Mode Prediction
Diaz, P., Phatak, S. S., Xu, J. J., Astruc‐Diaz, F., Cavasotto, C. N., & Naguib, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm801353p · Cited by 71
N-Acylethanolamines in Signal Transduction of Elicitor Perception. Attenuation of Alkalinization Response and Activation of Defense Gene Expression
Tripathy, S., Venables, B. J., & Chapman, K. D. (1999) · PLANT PHYSIOLOGY · doi:10.1104/pp.121.4.1299 · Cited by 71
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism
Underdown, N. J., Hiley, C. R., & Ford, W. R. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706391 · Cited by 71
Endogenous cannabinoids: Metabolism and their role in reproduction
Habayeb, O. M. H., Bell, S. C., & Konje, J. C. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01539-9 · Cited by 71
Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells
Skaper, S. D., Facci, L., Kee, W. J., & Strijbos, P. J. L. M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00008.x · Cited by 70
Self-citation
Cannabinoid receptor 2 is increased in acutely and chronically inflamed bladder of rats
Merriam, F. V., Wang, Z.-Y., GUÉRIOS, S. D., & Bjorling, D. E. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.08.076 · Cited by 70
Inhibition of the Cyclic AMP Signaling Cascade and Nuclear Factor Binding to CRE and κB Elements by Cannabinol, a Minimally CNS-Active Cannabinoid
Herring, A. C., Koh, W. S., & Kaminski, N. E. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00630-8 · Cited by 70
Selective Antiepileptic Effects ofN‐Palmitoylethanolamide, a Putative Endocannabinoid
Sheerin, A. H., Zhang, X., Saucier, D. M., & Corcoran, M. E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.16604.x · Cited by 70
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
Hiley, C. R., & Ford, W. R. (2004) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1017/s1464793103006201 · Cited by 70
Endocannabinoids and their actions
Maccarrone, M., & Finazzi‐Agrò, A. (2002) · Vitamins and hormones · doi:10.1016/s0083-6729(02)65066-6 · Cited by 69
Design and Synthesis of a Novel Series ofN-Alkyl Isatin Acylhydrazone Derivatives that Act as Selective Cannabinoid Receptor 2 Agonists for the Treatment of Neuropathic Pain
Diaz, P., Xu, J. J., Astruc‐Diaz, F., Pan, H.-M., Brown, D. L., & Naguib, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8002203 · Cited by 69
Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat
Murillo‐Rodríguez, E., Vázquez, E., Millán‐Aldaco, D., Palomero‐Rivero, M., & Drucker-Colı́n, R. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.01.076 · Cited by 69
Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries—A Systematic Review
Petrosino, S., & Moriello, A. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249526 · Cited by 68
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models
Caprioli, A., Coccurello, R., Rapino, C., Serio, S. D., Tommaso, M. D., Vertechy, M., Vacca, V., Battista, N., Pavone, F., Maccarrone, M., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.191403 · Cited by 68
Molecular Neurobiology of The Cannabinoid Receptor
Abood, M. E., & Martin, B. R. (1996) · International review of neurobiology · doi:10.1016/s0074-7742(08)60667-4 · Cited by 68
Pharmacological Evaluation of a Novel Cannabinoid 2 (CB2) Ligand, PF-03550096, In Vitro and In Vivo by Using a Rat Model of Visceral Hypersensitivity
Kikuchi, A., Ohashi, K., Sugie, Y., Sugimoto, H., & Omura, H. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071599 · Cited by 68
Bioactive long chain N-acylethanolamines in five species of edible bivalve molluscs
Sepe, N., PETROCELLIS, L. D., Montanaro, F., Cimino, G., & Marzo, V. D. (1998) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00132-x · Cited by 67
Arachidonylethanolamide Induces Apoptosis of Human Glioma Cells through Vanilloid Receptor-1
Contassot, E., Wilmotte, R., Tenan, M., Belkouch, M., Schnüriger, V., de Tribolet, N., Bourkhardt, K., & Dietrich, P. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.9.956 · Cited by 67
Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide
Bettoni, I., Comelli, F., Colombo, A., Bonfanti, P., & Costa, B. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312010008 · Cited by 66
Cannabimimetic fatty acid derivatives in cancer and inflammation
Marzo, V. D., Melck, D. J., PETROCELLIS, L. D., & Bisogno, T. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00054-x · Cited by 66
Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
Ueda, Y., Miyagawa, N., Matsui, T., Kaya, T., & IWAMURA, H. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.08.013 · Cited by 66
Functional and Immunohistochemical Characterization of CB1 and CB2 Receptors in Rat Bladder
Hayn, M. H., Ballesteros, I., Miguel, F. D., Coyle, C. H., Tyagi, S., Yoshimura, N., Chancellor, M. B., & Tyagi, P. (2008) · Urology · doi:10.1016/j.urology.2008.03.044 · Cited by 65
Contrasting Effects of WIN 55212–2 on Motility of the Rat Bladder and Uterus
Dmitrieva, N., & Berkley, K. J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07147.2002 · Cited by 65
The Role of Mast Cells in Stroke
Parrella, E., Porrini, V., Benarese, M., & Pizzi, M. (2019) · Cells · doi:10.3390/cells8050437 · Cited by 65
Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice
Ishida, T., Nishiumi, S., Tanahashi, T., Yamasaki, A., Yamazaki, A., Akashi, T., Miki, I., Kondo, Y., Inoue, J., Kawauchi, S., et al. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.030 · Cited by 64
Endocannabinoids and the gut
Pinto, L., Capasso, R., Carlo, G. D., & Izzo, A. A. (2002) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2001.0345 · Cited by 64
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis
Tambaro, S., Casu, M. A., Mastinu, A., & Lazzari, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.02.013 · Cited by 63
Anandamide and other N-acylethanolamines in mouse peritoneal macrophages
Schmid, P. C., Kuwae, T., Krebsbach, R. J., & Schmid, H. H. O. (1997) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(97)00032-7 · Cited by 62
Regulation of the cAMP cascade, gene expression and immune function by cannabinoid receptors
Kaminski, N. E. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(97)00228-2 · Cited by 62
A Pharmacological Rationale to Reduce the Incidence of Opioid Induced Tolerance and Hyperalgesia: A Review
Varrassi, G., Fusco, M., Skaper, S. D., Battelli, D., Zis, P., Coaccioli, S., Pace, M. C., & Paladini, A. (2018) · Pain and Therapy · doi:10.1007/s40122-018-0094-9 · Cited by 64
Self-citation
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury
Esposito, E., Cordaro, M., & Cuzzocrea, S. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.05.009 · Cited by 61
The Sleep Inducing Factor Oleamide Is Produced by Mouse Neuroblastoma Cells
Bisogno, T., Sepe, N., PETROCELLIS, L. D., Mechoulam, R., & Marzo, V. D. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7431 · Cited by 61
Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase
Reggio, P. H., & Traore, H. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00185-7 · Cited by 61
Cannabinomimetic Control of Mast Cell Mediator Release: New Perspective in Chronic Inflammation
Filippis, D. D., D’Amico, A., & Iuvone, T. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01674.x · Cited by 60
Quality of Life and a Surveillant Endocannabinoid System
Reis, R. A. D. M., Isaac, A. R., Freitas, H. R., de Almeida, M. M., Schuck, P. F., Ferreira, G. C., Andrade‐da‐Costa, B. L. D. S., & Trevenzoli, I. H. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.747229 · Cited by 63
HU 210: A Potent Tool for Investigations of the Cannabinoid System
Ottani, A., & Giuliani, D. (2001) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2001.tb00192.x · Cited by 60
Immunoregulatory effect of mast cells influenced by microbes in neurodegenerative diseases
Girolamo, F., Coppola, C., & Ribatti, D. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.06.017 · Cited by 61
GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
Im, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031034 · Cited by 62
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60
Allosteric regulation by oleamide of the binding properties of 5-hydroxytryptamine7 receptors
Hedlund, P. B., Carson, M. J., Sutcliffe, J. G., & Thomas, E. A. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00274-9 · Cited by 60
Topical adelmidrol 2% emulsion, a novel aliamide, in the treatment of mild atopic dermatitis in pediatric subjects: a pilot study.
Pulvirenti, N., Nasca, M. R., & Micali, G. (2007) · PubMed · Cited by 60
The endogenous cannabinoid anandamide, but not the CB2 ligand palmitoylethanolamide, prevents the viscero-visceral hyper-reflexia associated with inflammation of the rat urinary bladder
Jaggar, S., Sellaturay, S., & Rice, A. S. C. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00621-1 · Cited by 60
Expression and Functions of the CB2 Receptor in Human Leukocytes
Simard, M., Rakotoarivelo, V., Marzo, V. D., & Flamand, N. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.826400 · Cited by 59
Anti-Inflammatory Action of a Phosphatidylcholine, Phosphatidylethanolamine and N-Acylphosphatidylethanolamine-Enriched Diet in Carrageenan-Induced Pleurisy
Erős, G., Varga, G., Váradi, R., Czóbel, M., Kaszaki, J., Ghyczy, M., & Boros, M. (2008) · European Surgical Research · doi:10.1159/000167856 · Cited by 59
Targeting mast cells: a new way to treat endometriosis
Binda, M. M., Donnez, J., & Dolmans, M. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2017.1260548 · Cited by 59
Clinical and histological evaluation of an analogue of palmitoylethanolamide, PLR 120 (comicronized Palmidrol INN) in cats with eosinophilic granuloma and eosinophilic plaque: a pilot study
Scarampella, F., Abramo, F., & Noli, C. (2001) · Veterinary Dermatology · doi:10.1046/j.1365-3164.2001.00214.x · Cited by 59
Examining the roles of cannabinoids in pain and other therapeutic indications: a review
Turcotte, D., Dorze, J.-A. L., Esfahani, F., Frost, E. E., Gomori, A. J., & Namaka, M. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560903413534 · Cited by 59
The Interplay between the Immune and the Endocannabinoid Systems in Cancer
Braile, M., Marcella, S., Marone, G., Galdiero, M. R., Varricchi, G., & Loffredo, S. (2021) · Cells · doi:10.3390/cells10061282 · Cited by 62
Effect of acute administration of Pistacia lentiscus L. essential oil on rat cerebral cortex following transient bilateral common carotid artery occlusion
Quartu, M., Serra, M. P., Boi, M., Pillolla, G., Melis, T., Poddighe, L., Fiacco, M. D., Falconieri, D., Carta, G., Murru, E., et al. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-8 · Cited by 57
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model
Nam, G., Jeong, S. K., Park, B. M., Lee, S. H., Kim, H. J., Hong, S.-P., Kim, B. J., & Kim, B.-W. (2016) · Annals of Dermatology · doi:10.5021/ad.2016.28.1.22 · Cited by 57
Design, Synthesis, and In Vitro Evaluation of Carbamate Derivatives of 2-Benzoxazolyl- and 2-Benzothiazolyl-(3-hydroxyphenyl)-methanones as Novel Fatty Acid Amide Hydrolase Inhibitors
Myllymäki, M. J., Saario, S. M., Kataja, A. O., Castillo‐Melendez, J. A., Nevalainen, T., Juvonen, R. O., Järvinen, T., & Koskinen, A. M. P. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070501w · Cited by 57
The Endocannabinoid Signaling System: A Potential Target for Next- Generation Therapeutics for Alcoholism
Basavarajappa, B. S. (2007) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955707781387920 · Cited by 57
Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice
Zheng, J., Yu, T.-S., Li, X., Fan, Y., Ma, W.-X., Du, Y., Zhao, R., & Guan, D.-W. (2012) · International Journal of Legal Medicine · doi:10.1007/s00414-012-0741-3 · Cited by 56
Molecular Biology of Cannabinoid Receptors
Abood, M. E. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_3 · Cited by 56
The pharmacological activity of inhalation exposure to marijuana smoke in mice
Lichtman, A. H., Poklis, J. L., Poklis, A., Wilson, D. M., & Martin, B. R. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00205-2 · Cited by 56
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide
González, S. R., Romero, J., de Miguel, R., Lastres‐Becker, I., Villanúa, M. A., Makriyannis, A., Ramos, J. A., & Fernández‐Ruíz, J. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00251-9 · Cited by 56
Inhibition of the production of endothelium‐derived hyperpolarizing factor by cannabinoid receptor agonists
Fleming, I., Schermer, B., Popp, R., & Busse, R. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702381 · Cited by 56

Authors: Facci, L., Dal Toso, R., Romanello, S., Buriani, A., Skaper, S. D., & Leon, A.
Affiliations: Researchlife, Castelfranco Veneto (TV), Italy.
ORCID: Buriani, A
Skaper, S D
Venue: Proceedings of the National Academy of Sciences
Publisher: National Academy of Sciences
Published: 1995-04-11
Volume: 92
Issue: 8
Pages: 3376-3380
ISSN: 0027-8424 (ISSN-L)
1091-6490
DOI: 10.1073/pnas.92.8.3376
PMC: PMC42169
OpenAlex: W1998941878
Cited by: 632
References: 43
Citations by year: 2026: 4 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 10 · 2021: 13 · 2020: 16 · 2019: 24 · 2018: 13 · 2017: 19 · 2016: 16 · 2015: 11 · 2014: 19 · 2013: 24 · 2012: 28
FWCI: 23.55
Type: journal article
Language: en
Open access: green
europepmc.org
Locations: Proceedings of the National Academy of Sciences (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Keywords: mast cells, CB2 receptor, anandamide, palmitoylethanolamide, mast cell activation, inflammation, anti-inflammatory therapy, neuroimmune interactions
MeSH terms: Amides, Animals, Arachidonic Acids, Base Sequence, Cannabinoids, Cell Membrane, Cells, Cultured, Ethanolamines, Inflammation, Male, Mast Cells, Molecular Sequence Data, Morpholines, Naphthalenes, Palmitic Acids, Receptors, Drug, Receptors, Cell Surface, RNA, Messenger, Down-Regulation, Rats, Wistar, Molecular Mimicry, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Benzoxazines, Rats, Polyunsaturated Alkamides, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks